Director/PDMR Shareholding

RNS Number : 3905N

GlaxoSmithKline PLC

15 May 2015

 

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in interests in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned Executive Director on 14 May 2015:

	GSK Deferred Annual Bonus Plan
Sir Andrew Witty	Exercise of a nil priced option over 57,932 shares and 7,821 shares granted on 9 March 2012, both of which vested on 9 March 2015 under the GlaxoSmithKline Deferred Annual Bonus Plan. GlaxoSmithKline delivered the net of tax value in shares being 34,849.

The fair market value of an Ordinary Share at the point of exercise on 14 May 2015 was £14.14.

The Company and the above-mentioned Executive Director were advised of this transaction on 15 May 2015.

This notification relates to a transaction notified in accordance with paragraph 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

V A Whyte

Company Secretary

15 May 2015

 

END

 

 

RDSQELFFEEFFBBF